Loading...
Gemcitabine enhances antitumor efficacy of recombinant lipoimmunogen-based immunotherapy
Although immunotherapy is an attractive approach for cancer treatment, increasing evidence has shown that the combination of immunotherapy with other treatment modalities may improve the outcome of advanced malignancy. We combined the anticancer drug gemcitabine (Gem) with recombinant lipoprotein-ba...
Na minha lista:
| Udgivet i: | Oncoimmunology |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4839335/ https://ncbi.nlm.nih.gov/pubmed/27141356 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1095433 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|